BD published a third-party bulletin on November 6, 2020 for Zerologon, the Netlogon elevation of privilege vulnerability CVE-2020-1472. BD lists products that use affected Netlogon Remote Protocol versions: the Infusion, Supply and Medication Knowledge Portals, Intelliport, Kiestra InoqulA and ReadA Standalone, Kiestra TLA and WCA, and HealthSight Clinical Advisor, Data Manager, Diversion Management, Infection Advisor and Inventory Optimization.

BD has received no reports of exploitation on its products. Zerologon comes from a flaw in the protocol's cryptographic implementation, and it lets an attacker on the network take over a domain controller. Any BD server joined to a vulnerable domain inherits that risk, whatever its own patch level.